Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Core EBITDA Margin

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 42.5040.8637.7352.1439.14

What is the latest Core EBITDA Margin ratio of CONCORD BIOTECH ?

The latest Core EBITDA Margin ratio of CONCORD BIOTECH is 42.50 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202442.50
Mar202340.86
Mar202237.73
Mar202152.14
Mar202039.14

How is Core EBITDA Margin of CONCORD BIOTECH Trending?

Years Core EBITDA Margin % Change
Mar2024 42.5
4.01
Mar2023 40.86
8.30
Mar2022 37.73
-27.64
Mar2021 52.14
33.21
Mar2020 39.14 -

Other Financial Ratios of CONCORD BIOTECH


Compare Core EBITDA Margin ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹16,104.7 Cr 7.1% -7.4% -2.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -4.9% 2.1% 15.5% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.2% 9.3% 50.5% Stock Analytics
CIPLA ₹119,410.0 Cr -4.2% 4.5% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -4.4% -4.5% 17.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -1.4% 4.2% -8.8% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

7.1%

-7.4%

-2.7%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses